FTC targeting healthcare private equity deals: What ASCs need to know

The Federal Trade Commission has taken aim against a private-equity firms' healthcare deal in a move regulators say could spell trouble for other healthcare agreements the agency deems anticompetitive,  The Wall Street Journal reported recently.

Read the full post at Becker's ASC
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive